Yongjun Li

Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6

Zhuoxian Cao, Zhicheng Gu, Shuxian Lin et al. · ACS Chemical Biology · 2021 · 62 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

Design, synthesis, molecular modeling, and biological evaluation of novel kojic acid derivatives containing bioactive heterocycle moiety as inhibitors of tyrosinase and antibrowning agents

Min He, Meiyan Fan, Wenjing Liu et al. · Food Chemistry · 2021 · 60 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer

Zhuoxian Cao, Fen‐Fen Yang, Jie Wang et al. · Journal of Medicinal Chemistry · 2021 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors

Guangcheng Wang, Zhiyun Peng, Zipeng Gong et al. · Bioorganic Chemistry · 2018 · 49 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma

Baoliang Li, Hao Huang, Ronghai Huang et al. · Disease Markers · 2020 · 43 citations · Full text

Medicine, Molecular Medicine, Oncology +17